APO Research

APO RESEARCH · REPORT

Eucommia Ulmoides Granules

Selected research

Industry Research

Eucommia Ulmoides Granules Industry Research Report 2026

Market perspective

The global Eucommia Ulmoides Granules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Eucommia Ulmoides Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Eucommia Ulmoides Granules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Eucommia Ulmoides Granules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Eucommia Ulmoides Granules include Guizhou Runsheng Pharmaceutical Co., Ltd., Guizhou Shenqi Pharmaceutical Co., Ltd., Guizhou Shengjitang Pharmaceutical Co., Ltd., Huangshan Tianmu Pharmaceutical Co., Ltd., Huiyinbi Group Anhui Pharmaceutical Co., Ltd., Jilin Zixin Pharmaceutical Co., Ltd., Nanjing Tongrentang Pharmaceutical Co., Ltd., Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Eucommia Ulmoides Granules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Eucommia Ulmoides Granules Market by Company

Guizhou Runsheng Pharmaceutical Co., Ltd.

Guizhou Shenqi Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Huangshan Tianmu Pharmaceutical Co., Ltd.

Huiyinbi Group Anhui Pharmaceutical Co., Ltd.

Jilin Zixin Pharmaceutical Co., Ltd.

Nanjing Tongrentang Pharmaceutical Co., Ltd.

Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.

Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.

Sichuan Shenghe Pharmaceutical Co., Ltd.

Wuhu Luye Pharmaceutical Co., Ltd.

Xi'an Zhengda Pharmaceutical Co., Ltd.

Eucommia Ulmoides Granules Segment by Type

5g Per Bag

10g Per Bag

Eucommia Ulmoides Granules Segment by Application

Hospital

Clinic

Other

Eucommia Ulmoides Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eucommia Ulmoides Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eucommia Ulmoides Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eucommia Ulmoides Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Eucommia Ulmoides Granules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Eucommia Ulmoides Granules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Eucommia Ulmoides Granules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Eucommia Ulmoides Granules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Eucommia Ulmoides Granules Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Eucommia Ulmoides Granules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Eucommia Ulmoides Granules Revenue of Manufacturers (2021-2026) Table 9. Global Eucommia Ulmoides Granules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Eucommia Ulmoides Granules Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Eucommia Ulmoides Granules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Eucommia Ulmoides Granules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Eucommia Ulmoides Granules, Product Type & Application Table 14. Global Eucommia Ulmoides Granules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Eucommia Ulmoides Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Guizhou Runsheng Pharmaceutical Co., Ltd. Company Information Table 19. Guizhou Runsheng Pharmaceutical Co., Ltd. Business Overview Table 20. Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 22. Guizhou Runsheng Pharmaceutical Co., Ltd. Recent Developments Table 23. Guizhou Shenqi Pharmaceutical Co., Ltd. Company Information Table 24. Guizhou Shenqi Pharmaceutical Co., Ltd. Business Overview Table 25. Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 27. Guizhou Shenqi Pharmaceutical Co., Ltd. Recent Developments Table 28. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 29. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 30. Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 32. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments Table 33. Huangshan Tianmu Pharmaceutical Co., Ltd. Company Information Table 34. Huangshan Tianmu Pharmaceutical Co., Ltd. Business Overview Table 35. Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 37. Huangshan Tianmu Pharmaceutical Co., Ltd. Recent Developments Table 38. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Company Information Table 39. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Business Overview Table 40. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 42. Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Recent Developments Table 43. Jilin Zixin Pharmaceutical Co., Ltd. Company Information Table 44. Jilin Zixin Pharmaceutical Co., Ltd. Business Overview Table 45. Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 47. Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments Table 48. Nanjing Tongrentang Pharmaceutical Co., Ltd. Company Information Table 49. Nanjing Tongrentang Pharmaceutical Co., Ltd. Business Overview Table 50. Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 52. Nanjing Tongrentang Pharmaceutical Co., Ltd. Recent Developments Table 53. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Company Information Table 54. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Business Overview Table 55. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 57. Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Recent Developments Table 58. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information Table 59. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview Table 60. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 62. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Developments Table 63. Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information Table 64. Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview Table 65. Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 67. Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments Table 68. Wuhu Luye Pharmaceutical Co., Ltd. Company Information Table 69. Wuhu Luye Pharmaceutical Co., Ltd. Business Overview Table 70. Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 72. Wuhu Luye Pharmaceutical Co., Ltd. Recent Developments Table 73. Xi'an Zhengda Pharmaceutical Co., Ltd. Company Information Table 74. Xi'an Zhengda Pharmaceutical Co., Ltd. Business Overview Table 75. Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio Table 77. Xi'an Zhengda Pharmaceutical Co., Ltd. Recent Developments Table 78. Global Eucommia Ulmoides Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Eucommia Ulmoides Granules Sales by Region (2021-2026) & (K Units) Table 80. Global Eucommia Ulmoides Granules Sales Market Share by Region (2021-2026) Table 81. Global Eucommia Ulmoides Granules Sales by Region (2027-2032) & (K Units) Table 82. Global Eucommia Ulmoides Granules Sales Market Share by Region (2027-2032) Table 83. Global Eucommia Ulmoides Granules Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Eucommia Ulmoides Granules Revenue Market Share by Region (2021-2026) Table 85. Global Eucommia Ulmoides Granules Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Eucommia Ulmoides Granules Revenue Market Share by Region (2027-2032) Table 87. North America Eucommia Ulmoides Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 89. North America Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 90. North America Eucommia Ulmoides Granules Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Eucommia Ulmoides Granules Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Eucommia Ulmoides Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 94. Europe Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 95. Europe Eucommia Ulmoides Granules Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Eucommia Ulmoides Granules Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Eucommia Ulmoides Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Eucommia Ulmoides Granules Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Eucommia Ulmoides Granules Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Eucommia Ulmoides Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 104. South America Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 105. South America Eucommia Ulmoides Granules Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Eucommia Ulmoides Granules Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Eucommia Ulmoides Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Eucommia Ulmoides Granules Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Eucommia Ulmoides Granules Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Eucommia Ulmoides Granules Sales by Type (2021-2026) & (K Units) Table 113. Global Eucommia Ulmoides Granules Sales by Type (2027-2032) & (K Units) Table 114. Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2026) Table 115. Global Eucommia Ulmoides Granules Sales Market Share by Type (2027-2032) Table 116. Global Eucommia Ulmoides Granules Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Eucommia Ulmoides Granules Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2026) Table 119. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2027-2032) Table 120. Global Eucommia Ulmoides Granules Price by Type (2021-2026) & (US$/Unit) Table 121. Global Eucommia Ulmoides Granules Price by Type (2027-2032) & (US$/Unit) Table 122. Global Eucommia Ulmoides Granules Sales by Application (2021-2026) & (K Units) Table 123. Global Eucommia Ulmoides Granules Sales by Application (2027-2032) & (K Units) Table 124. Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2026) Table 125. Global Eucommia Ulmoides Granules Sales Market Share by Application (2027-2032) Table 126. Global Eucommia Ulmoides Granules Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Eucommia Ulmoides Granules Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2026) Table 129. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2027-2032) Table 130. Global Eucommia Ulmoides Granules Price by Application (2021-2026) & (US$/Unit) Table 131. Global Eucommia Ulmoides Granules Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Eucommia Ulmoides Granules Distributors List Table 135. Eucommia Ulmoides Granules Customers List Table 136. Eucommia Ulmoides Granules Industry Trends Table 137. Eucommia Ulmoides Granules Industry Drivers Table 138. Eucommia Ulmoides Granules Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Eucommia Ulmoides Granules Product Image Figure 5. Global Eucommia Ulmoides Granules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Eucommia Ulmoides Granules Market Size (2021-2032) & (US$ Million) Figure 7. Global Eucommia Ulmoides Granules Sales (2021-2032) & (K Units) Figure 8. Global Eucommia Ulmoides Granules Average Price (US$/Unit) & (2021-2032) Figure 9. 5g Per Bag Product Image Figure 10. 10g Per Bag Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Eucommia Ulmoides Granules Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Eucommia Ulmoides Granules, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Eucommia Ulmoides Granules Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Eucommia Ulmoides Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Eucommia Ulmoides Granules Sales by Region in 2025 Figure 20. Global Eucommia Ulmoides Granules Revenue by Region in 2025 Figure 21. North America Eucommia Ulmoides Granules Market Size by Country in 2025 Figure 22. North America Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 23. North America Eucommia Ulmoides Granules Revenue Market Share by Country (2021-2032) Figure 24. United States Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Eucommia Ulmoides Granules Market Size by Country in 2025 Figure 28. Europe Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 29. Europe Eucommia Ulmoides Granules Revenue Market Share by Country (2021-2032) Figure 30. Germany Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Eucommia Ulmoides Granules Market Size by Country in 2025 Figure 41. Asia Pacific Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Eucommia Ulmoides Granules Revenue Market Share by Country (2021-2032) Figure 43. China Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Eucommia Ulmoides Granules Market Size by Country in 2025 Figure 52. South America Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 53. South America Eucommia Ulmoides Granules Revenue Market Share by Country (2021-2032) Figure 54. Brazil Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Eucommia Ulmoides Granules Market Size by Country in 2025 Figure 58. Middle East and Africa Eucommia Ulmoides Granules Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Eucommia Ulmoides Granules Revenue Market Share by Country (2021-2032) Figure 60. Egypt Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Eucommia Ulmoides Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2032) Figure 66. Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2032) Figure 67. Global Eucommia Ulmoides Granules Price (US$/Unit) by Type (2021-2032) Figure 68. Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2032) Figure 69. Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2032) Figure 70. Global Eucommia Ulmoides Granules Price (US$/Unit) by Application (2021-2032) Figure 71. Eucommia Ulmoides Granules Value Chain Figure 72. Eucommia Ulmoides Granules Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Eucommia Ulmoides Granules Industry Opportunities and Challenges

Scope & coverage.

Types
  • 5g Per Bag
  • 10g Per Bag
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guizhou Runsheng Pharmaceutical Co., Ltd.
  • Guizhou Shenqi Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Huangshan Tianmu Pharmaceutical Co., Ltd.
  • Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • Nanjing Tongrentang Pharmaceutical Co., Ltd.
  • Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
  • Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  • Sichuan Shenghe Pharmaceutical Co., Ltd.
  • Wuhu Luye Pharmaceutical Co., Ltd.
  • Xi'an Zhengda Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Eucommia Ulmoides Granules Market Size (2021-2032)
  4. 2.2.2 Global Eucommia Ulmoides Granules Sales (2021-2032)
  5. 2.2.3 Global Eucommia Ulmoides Granules Market Average Price (2021-2032)
  6. 2.3 Eucommia Ulmoides Granules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 5g Per Bag
  9. 2.3.3 10g Per Bag
  10. 2.4 Eucommia Ulmoides Granules by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Eucommia Ulmoides Granules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Eucommia Ulmoides Granules Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Eucommia Ulmoides Granules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Eucommia Ulmoides Granules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Eucommia Ulmoides Granules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Eucommia Ulmoides Granules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Eucommia Ulmoides Granules, Product Type & Application
  8. 3.8 Global Manufacturers of Eucommia Ulmoides Granules, Established Date
  9. 3.9 Global Eucommia Ulmoides Granules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Guizhou Runsheng Pharmaceutical Co., Ltd.
  2. 4.1.1 Guizhou Runsheng Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Guizhou Runsheng Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  6. 4.1.5 Guizhou Runsheng Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Guizhou Shenqi Pharmaceutical Co., Ltd.
  8. 4.2.1 Guizhou Shenqi Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Guizhou Shenqi Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  12. 4.2.5 Guizhou Shenqi Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  14. 4.3.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  18. 4.3.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Huangshan Tianmu Pharmaceutical Co., Ltd.
  20. 4.4.1 Huangshan Tianmu Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Huangshan Tianmu Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  24. 4.4.5 Huangshan Tianmu Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
  26. 4.5.1 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  30. 4.5.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Jilin Zixin Pharmaceutical Co., Ltd.
  32. 4.6.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  36. 4.6.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Nanjing Tongrentang Pharmaceutical Co., Ltd.
  38. 4.7.1 Nanjing Tongrentang Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Nanjing Tongrentang Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  42. 4.7.5 Nanjing Tongrentang Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
  44. 4.8.1 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  48. 4.8.5 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  50. 4.9.1 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  54. 4.9.5 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Sichuan Shenghe Pharmaceutical Co., Ltd.
  56. 4.10.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  60. 4.10.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Wuhu Luye Pharmaceutical Co., Ltd.
  62. 4.11.1 Wuhu Luye Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Wuhu Luye Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  66. 4.11.5 Wuhu Luye Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Xi'an Zhengda Pharmaceutical Co., Ltd.
  68. 4.12.1 Xi'an Zhengda Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Xi'an Zhengda Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolio
  72. 4.12.5 Xi'an Zhengda Pharmaceutical Co., Ltd. Recent Developments
5 Global Eucommia Ulmoides Granules Market Scenario by Region
  1. 5.1 Global Eucommia Ulmoides Granules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Eucommia Ulmoides Granules Sales by Region: 2021-2032
  3. 5.2.1 Global Eucommia Ulmoides Granules Sales by Region: 2021-2026
  4. 5.2.2 Global Eucommia Ulmoides Granules Sales by Region: 2027-2032
  5. 5.3 Global Eucommia Ulmoides Granules Revenue by Region: 2021-2032
  6. 5.3.1 Global Eucommia Ulmoides Granules Revenue by Region: 2021-2026
  7. 5.3.2 Global Eucommia Ulmoides Granules Revenue by Region: 2027-2032
  8. 5.4 North America Eucommia Ulmoides Granules Market Facts & Figures by Country
  9. 5.4.1 North America Eucommia Ulmoides Granules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Eucommia Ulmoides Granules Sales by Country (2021-2032)
  11. 5.4.3 North America Eucommia Ulmoides Granules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Eucommia Ulmoides Granules Market Facts & Figures by Country
  16. 5.5.1 Europe Eucommia Ulmoides Granules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Eucommia Ulmoides Granules Sales by Country (2021-2032)
  18. 5.5.3 Europe Eucommia Ulmoides Granules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Eucommia Ulmoides Granules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Eucommia Ulmoides Granules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Eucommia Ulmoides Granules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Eucommia Ulmoides Granules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Eucommia Ulmoides Granules Market Facts & Figures by Country
  41. 5.7.1 South America Eucommia Ulmoides Granules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Eucommia Ulmoides Granules Sales by Country (2021-2032)
  43. 5.7.3 South America Eucommia Ulmoides Granules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Eucommia Ulmoides Granules Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Eucommia Ulmoides Granules Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Eucommia Ulmoides Granules Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Eucommia Ulmoides Granules Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Eucommia Ulmoides Granules Sales by Type (2021-2032)
  2. 6.1.1 Global Eucommia Ulmoides Granules Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Eucommia Ulmoides Granules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Eucommia Ulmoides Granules Revenue by Type (2021-2032)
  5. 6.2.1 Global Eucommia Ulmoides Granules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Eucommia Ulmoides Granules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Eucommia Ulmoides Granules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Eucommia Ulmoides Granules Sales by Application (2021-2032)
  2. 7.1.1 Global Eucommia Ulmoides Granules Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Eucommia Ulmoides Granules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Eucommia Ulmoides Granules Revenue by Application (2021-2032)
  5. 7.2.1 Global Eucommia Ulmoides Granules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Eucommia Ulmoides Granules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Eucommia Ulmoides Granules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Eucommia Ulmoides Granules Value Chain Analysis
  2. 8.1.1 Eucommia Ulmoides Granules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Eucommia Ulmoides Granules Production Mode & Process
  5. 8.2 Eucommia Ulmoides Granules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Eucommia Ulmoides Granules Distributors
  8. 8.2.3 Eucommia Ulmoides Granules Customers
9 Global Eucommia Ulmoides Granules Analyzing Market Dynamics
  1. 9.1 Eucommia Ulmoides Granules Industry Trends
  2. 9.2 Eucommia Ulmoides Granules Industry Drivers
  3. 9.3 Eucommia Ulmoides Granules Industry Opportunities and Challenges
  4. 9.4 Eucommia Ulmoides Granules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research